AADI Enlists NY Court To Enforce Cancer Drug Award

By Caroline Simson · December 11, 2024, 9:06 PM EST

California-based AADI Bioscience Inc. is asking a New York federal court to enforce an arbitral award rejecting a more than $15 million claim asserted by a Hong Kong biopharmaceutical company following...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Aadi Bioscience, Inc. v. EOC Pharma (Hong Kong) Limited

Case Number

1:24-cv-09412

Court

New York Southern

Nature of Suit

Other Statutes: Arbitration

Date Filed

December 10, 2024